Leave Your Message

Tlhaloso e Pharalletseng ea Kalafo ea Groundbreaking Leukemia

CAR-T Therapy, e khuts'oane bakeng sa Chimeric Antigen Receptor T-Cell Immunotherapy, ke mokhoa o tsoetseng pele oa kalafo o kenyelletsang ho fetola liphatsa tsa lefutso liseleng tsa T tsa mokuli ho lebisa le ho senya lisele tsa mofetše. Ho fapana le meriana ea setso, phekolo ea CAR-T e etselitsoe mokuli e mong le e mong ’me e hloka ho bokella lisele tsa T maling a mokuli pele li li khutlisetsa ’meleng ka mor’a boenjiniere ba liphatsa tsa lefutso.

    Lipontšo tsa CAR-T

    B-cell acute lymphoblastic leukemia

    Myeloma e mengata

    Chronic lymphocytic leukemia

    Non-Hodgkin lymphoma

    E hasanya B-cell lymphoma e kholo

    SLE (System Lupus Erythematosus)

    Myasthenia gravis

    Mafu a mang a autoimmune

    Ts'ebetso e ntle ea kliniki ea CAR-T

    Matšoao a CD19+20CAR-T:Bakuli ba nang le B-cell non Hodgkin's lymphoma

    Sekhahla sa CR sa khoeli e le 'ngoe

    Sekhahla sa PR sa khoeli e le 'ngoe

    Khoeli e le 'ngoe KAPA reiti

    CRS≥3

    CRES≥3

    71.95% (59/82)

    25.6 (21/82)

    97.55 (80/82)

    12.19% (10/82)

    0

    Matšoao a CD19+22CAR-T:Kalafo ea bakuli ba CD19 ba khutletseng morao le ba refractory acute B-lymphocytic leukemia

    Sekhahla sa CR sa khoeli e le 'ngoe

    Sekhahla sa PR sa khoeli e le 'ngoe

    Khoeli e le 'ngoe KAPA reiti

    CRS≥3

    CRES≥3

    92.1% (35/38)

    7.9% (3/38)

    100% (38/38)

    15.79% (6/38)

    0

    Matšoao a BCMACAR-T:Kalafo ea ho khutlela morao le ho hanyetsa multiple myeloma

    Sekhahla sa CR sa khoeli e le 'ngoe

    Sekhahla sa PR sa khoeli e le 'ngoe

    Khoeli e le 'ngoe KAPA reiti

    CRS≥3

    CRES≥3

    72.41% (21/29)

    27.59% (8/29)

    100% (29/29)

    6.9% (2/29)

    0

    KAKARETSO EA PHEKO EA CAR-T (2)tch

    Melemo ea Rōna

     Kalafo ea Motho: Kalafo e 'ngoe le e' ngoe ea CAR-T e etselitsoe mokuli, ho netefatsa liphello tse lebisitsoeng haholo le tse sebetsang tsa phekolo.

     Likhetho tse fapaneng tsa ho Lebela: Ka mefuta e mengata ea li-antigen tse lebisitsoeng, ho kenyeletsoa CD7, CD19, CD20, CD22, le BCMA, lihlahisoa tsa rona tsa CAR-T li fana ka mefuta-futa e ke keng ea lekanngoa ho phekola mafu a sa tšoaneng a hematological le mafu a autoimmune.

     Pakiloeng Clinical Katleho: Liphekolo tsa rona tsa CAR-T li bonts'itse katleho e ikhethang ho pholletsa le linyeoe tse ngata tsa bongaka, ka litekanyetso tse tsotehang tsa phokolo le litlaleho tsa polokeho, tse matlafatsang boemo ba rona ba ho ba moetapele oa immunotherapy.

     Litsenyehelo tse Phahameng ka ho Fetisisa: Re fana ka monyetla oa tlholisano ka liphekolo tsa boleng bo holimo ka litheko tse fumanehang habonolo ha li bapisoa le lihlahisoa tse ling tsa CAR-T 'marakeng.

     Theknoloji e tsoetseng pele: Ho sebelisa tsoelo-pele ea morao-rao ea boenjiniere ba liphatsa tsa lefutso, liphekolo tsa rona tsa CAR-T li kenyelletsa bokamoso ba mofetše le kalafo ea lefu la autoimmune.

     Setsebi sa Tšehetso ea Bongaka: Sehlopha sa rona sa lingaka le bafuputsi ba nang le phihlelo se fana ka tlhokomelo e feletseng ho tloha lipuisanong tsa pele ka tsamaiso ea phekolo le ho latela.

    Lisele tsa CAR-T li se li tsebahala haholo ka katleho ea tsona ho bakuli ba sa kang ba arabela kalafo ea setso joalo ka chemotherapy kapa transplantation ea masapo. Setsi sa lefats'e sa bongaka se amohela monyetla o moholo oa phekolo ea CAR-T ho fetola liphello tsa bakuli.

    tlhaloso2

    Fill out my online form.